drugset / Trial / NCT00812643

Excretion of Radiolabelled AZD0837

NCT00812643

Phase 1 Completed 8 enrolled AstraZeneca
NaSingle-groupOpen-label

Summary

This is an explorative study and the scientific question to be investigated in this study is if AZD0837 and/or its metabolites AR-H069927XX and AR-H067637XX and other unknown metabolites are excreted into the bile.

Timeline

Start
2009-01
Primary completion
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject ATECEGATRAN METOXIL Small molecule Other

Indications

No indication recorded.